High Quality Hair Loss Treatment Enzalutamide CAS 915087-33-1 Enzalutamide

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: QS-Enzalutamide
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Powder
• Purity: >99%
• Model No.: QS-Enzalutamide
• Product Name: Enzalutamide
• Appearance: White to off-White Crystalline Powder
• Color: White/off-White
• Grade: Pharmaceutical Grade (USP/Ep Compliant)
• Test Method: HPLC (High-Performance Liquid Chromatography)
• CAS: 915087-33-1
• Molecular Formula: C21h26f4n4o2s
• Molecular Weight: 464.43 G/Mol
• Melting Point: 215–218°c (DEC.)
• Density: ~1.4 G/Cm³ (Estimated)
• Particle Size: ≤100 μm (90% Passing)
• Hygroscopicity: Slightly Hygroscopic
• Application: Nonsteroidal Antiandrogen
• Psa: 92.7 Ų
• Transport Package: Negotiable
• Specification: Pharmaceutical Grade
• Trademark: QS
• Origin: Xian
• Production Capacity: 50kg/Month

Product Description

High Quality Hair Loss Treatment Enzalutamide CAS 915087-33-1 Enzalutamide

Product Description

Product Details

Product Name	Enzalutamide
Appearance	White to off-white powder
Assay	99%
MF	C21H26F4N4O2S
MW	464.43

Enzalutamide (MDV 3100) is an androgen receptor antagonist that blocks the binding of androgens to androgen receptors and prevents the nuclear translocation of ligand-receptor complexes and the recruitment of co-activators. MDV3100 has also been shown to induce apoptosis in tumor cells and lacks agonist activity. MDV3100 is a candidate for the treatment of castration-resistant prostate cancer. Chinese name: Enzalutamide.

Application&Function

Enzalutamide is an androgen receptor inhibitor, which can competitively inhibit the binding of androgens to receptors, and also can inhibit the nuclear translocation of androgen receptors as well as the interaction between these receptors and DNA. In vitro experimental studies have shown that enzalutamide can inhibit the proliferation of prostate cancer cells and induce their death. In the model experiments of xenograft of prostate cancer in mice, enzalutamide can reduce the tumor volume [6]. The main metabolite of enzalutamide is N-demethyl enzalutamide, which shows similar inhibitory activity to enzalutamide in vitro.

Specification

Packaging & Shipping

ABOUT US